On February 4, 2022 Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer, autoimmune, and infectious diseases, reported that company management will participate in the following upcoming investor conferences (Press release, Asher Biotherapeutics, FEB 4, 2022, View Source [SID1234607762]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

4th Annual Guggenheim Oncology Conference
Craig Gibbs, Ph.D., will present a corporate overview on Friday, February 11, 2022 at 1:00 p.m. ET (10:00 a.m. PT). Company management will also participate in 1×1 meetings on Friday, February 11, 2022.

SVB Leerink 11th Annual Global Healthcare Conference
Company management will participate in 1×1 meetings on Monday, February 14 and Tuesday, February 15, 2022.